These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27863360)

  • 21. Association Between β-Blockers and Outcomes in Heart Failure With Preserved Ejection Fraction: Current Insights From the SwedeHF Registry.
    Meyer M; Du Fay Lavallaz J; Benson L; Savarese G; Dahlström U; Lund LH
    J Card Fail; 2021 Nov; 27(11):1165-1174. PubMed ID: 33971289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of calcium channel blockers in patients with heart failure with preserved ejection fraction: A protocol for systematic review and meta-analysis.
    Fukuta H; Goto T; Kamiya T
    PLoS One; 2024; 19(8):e0307258. PubMed ID: 39159218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are beta-blockers effective in heart failure with preserved ejection fraction?
    Alegría J; Rada G
    Medwave; 2016 Nov; 16(Suppl5):e6593. PubMed ID: 27813500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-blockers withdrawal in patients with heart failure with preserved ejection fraction and chronotropic incompetence: Effect on functional capacity rationale and study design of a prospective, randomized, controlled trial (The Preserve-HR trial).
    Palau P; Seller J; Domínguez E; Gómez I; Ramón JM; Sastre C; de la Espriella R; Santas E; Miñana G; Chorro FJ; González-Juanatey JR; Núñez J
    Clin Cardiol; 2020 May; 43(5):423-429. PubMed ID: 32073676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis of the effect of statins on mortality in patients with preserved ejection fraction.
    Liu G; Zheng XX; Xu YL; Ru J; Hui RT; Huang XH
    Am J Cardiol; 2014 Apr; 113(7):1198-204. PubMed ID: 24513478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-blocker use and cardiovascular event risk in patients with heart failure with preserved ejection fraction.
    Tsujimoto T; Kajio H
    Sci Rep; 2018 Jun; 8(1):9556. PubMed ID: 29934526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of elevated heart rate on clinical outcomes in patients with heart failure with reduced and preserved ejection fraction: a report from the CHART-2 Study.
    Takada T; Sakata Y; Miyata S; Takahashi J; Nochioka K; Miura M; Tadaki S; Shimokawa H;
    Eur J Heart Fail; 2014 Mar; 16(3):309-16. PubMed ID: 24464774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.
    Cheng RK; Cox M; Neely ML; Heidenreich PA; Bhatt DL; Eapen ZJ; Hernandez AF; Butler J; Yancy CW; Fonarow GC
    Am Heart J; 2014 Nov; 168(5):721-30. PubMed ID: 25440801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial.
    Edelmann F; Musial-Bright L; Gelbrich G; Trippel T; Radenovic S; Wachter R; Inkrot S; Loncar G; Tahirovic E; Celic V; Veskovic J; Zdravkovic M; Lainscak M; Apostolović S; Neskovic AN; Pieske B; Düngen HD;
    JACC Heart Fail; 2016 Feb; 4(2):140-149. PubMed ID: 26682793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials.
    Fukuta H; Hagiwara H; Kamiya T
    Int J Cardiol Heart Vasc; 2022 Oct; 42():101103. PubMed ID: 36032269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of beta-blockers on mortality in patients with heart failure and atrial fibrillation: A meta-analysis of observational cohort and randomized controlled studies.
    Ma GG; Fang Q; Wang FX
    Cardiol J; 2019; 26(6):744-752. PubMed ID: 30009373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. β-Blocker therapy in heart failure with preserved ejection fraction: Importance of dose and duration.
    Yamamoto K
    J Cardiol; 2015 Sep; 66(3):189-94. PubMed ID: 25881728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heart failure preserved ejection fraction (HFpEF): an integrated and strategic review.
    Lekavich CL; Barksdale DJ; Neelon V; Wu JR
    Heart Fail Rev; 2015 Nov; 20(6):643-53. PubMed ID: 26404098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trials.
    Brunner-La Rocca HP; Eurlings L; Richards AM; Januzzi JL; Pfisterer ME; Dahlström U; Pinto YM; Karlström P; Erntell H; Berger R; Persson H; O'Connor CM; Moertl D; Gaggin HK; Frampton CM; Nicholls MG; Troughton RW
    Eur J Heart Fail; 2015 Dec; 17(12):1252-61. PubMed ID: 26419999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heart failure: what does ejection fraction have to do with it?
    Iwano H; Little WC
    J Cardiol; 2013 Jul; 62(1):1-3. PubMed ID: 23672790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response.
    Kao DP; Lewsey JD; Anand IS; Massie BM; Zile MR; Carson PE; McKelvie RS; Komajda M; McMurray JJ; Lindenfeld J
    Eur J Heart Fail; 2015 Sep; 17(9):925-35. PubMed ID: 26250359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.
    Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L;
    Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of beta-blocker withdrawal in patients with heart failure with preserved ejection fraction: A protocol for systematic review and meta-analysis.
    Fukuta H; Goto T; Kamiya T
    PLoS One; 2023; 18(11):e0294347. PubMed ID: 37972075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of global region on outcomes in heart failure β-blocker trials.
    O'Connor CM; Fiuzat M; Swedberg K; Caron M; Koch B; Carson PE; Gattis-Stough W; Davis GW; Bristow MR
    J Am Coll Cardiol; 2011 Aug; 58(9):915-22. PubMed ID: 21851879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different prognostic associations of beta-blockers and diuretics in heart failure with preserved ejection fraction with versus without high blood pressure.
    Matsushita K; Harada K; Miyazaki T; Miyamoto T; Kohsaka S; Iida K; Tanimoto S; Takei M; Hosoda T; Yamamoto Y; Shiraishi Y; Yoshino H; Yamamoto T; Nagao K; Takayama M
    J Hypertens; 2019 Mar; 37(3):643-649. PubMed ID: 30234786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.